NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/06/2024
Back to search
Official data from USPTO
ABILIFY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
02/06/2024
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
06/13/2002
Registration date
10/07/2003
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/06/2024
Last transaction
02/06/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/19/2002
First use in commerce
11/19/2002
Drawing code
1
Owner type
03
Owner location
TOKYO, JP
Examiner
ABRAMS, JACQUELINE WILLETTE
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
OTSUKA PHARMACEUTICAL CO., LTD.
Bristol-Myers Squibb Company
Representatives
Scott S. Havlick Holland & Hart LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment and prevention of cardiovascular diseasescentral nervous system diseases and disordersstrokecancerinflammation and inflammatory diseasesrespiratory and infectious diseasesauto-immune diseasesantibiotics
Publications
History of USPTO decisions and trademark events.
37 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
02/06/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/06/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/06/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
08/10/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/07/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/02/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/02/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/02/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/02/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
07/19/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/18/2008
PLGL
ASSIGNED TO PARALEGAL
11/04/2008
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
10/24/2008
PAPER RECEIVED
10/24/2008
CORV
REVIEW OF CORRESPONDENCE COMPLETE
03/10/2008
PAPER RECEIVED
03/05/2008
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/30/2008
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
01/31/2006
PLGL
ASSIGNED TO PARALEGAL
12/01/2005
AMD7
SEC 7 REQUEST FILED
08/15/2005
PAPER RECEIVED
08/15/2005
R.PR
REGISTERED-PRINCIPAL REGISTER
10/07/2003
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/08/2003
DOCK
ASSIGNED TO EXAMINER
07/29/2003
CFIT
CASE FILE IN TICRS
07/24/2003
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/26/2003
EX1G
SOU EXTENSION 1 GRANTED
06/05/2003
IUAF
USE AMENDMENT FILED
05/01/2003
EISU
TEAS STATEMENT OF USE RECEIVED
05/01/2003
EXT1
SOU EXTENSION 1 FILED
04/11/2003
EEXT
SOU TEAS EXTENSION RECEIVED
04/11/2003
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
03/18/2003
PUBO
PUBLISHED FOR OPPOSITION
12/24/2002
NPUB
NOTICE OF PUBLICATION
12/04/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/24/2002
DOCK
ASSIGNED TO EXAMINER
10/11/2002
Continuous trademark protection
Get notified about every new filing that threatens ABILIFY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.